Brightfield Group | ECRM: CBD: FDA Impact & the Path Forward  8/16/2022

2022 Mid-Year US CBD Report

As the CBD industry moves forward without much-needed federal guidance, this year we've forecasted for two scenarios - with and without FDA regulation. This report will help you prepare for either eventuality while adding insights into top performers and key distribution channels.

You'll learn:

  • What's the projected revenue of the CBD market through 2027?
  • What is the forecasted impact of federal regulation?
  • Which brands are on top?
  • Which industry leaders are growing the fastest?
  • Which brands perform best in brick-and-mortar stores vs. online?
  • How the grocery channel is responding to risk, and which product types are pulling ahead as a result?
  • And much more


Click here to download the report.


Sarah Davidson

SVP of Grocery

Sarah Davidson is ECRM's SVP of Grocery, and can be reached at 440-542-3033

Post a Comment

Log in to Comment